Global GABA Receptor Modulators Supply, Demand and Key Producers, 2026-2032
The global GABA Receptor Modulators market size is expected to reach $ 15393 million by 2032, rising at a market growth of 4.3% CAGR during the forecast period (2026-2032).
GABA receptor modulators are prescription medicines that act directly on GABAA or GABAB receptors and alter inhibitory neurotransmission through agonism, positive allosteric modulation, or receptor antagonism. Commercial products mainly include benzodiazepines, Z-drug hypnotics, barbiturates, selected intravenous anesthetics and sedatives, neuroactive steroids, baclofen, and oxybate-based medicines. Clinical applications include anxiety disorders, insomnia, epilepsy and seizures, anesthesia and procedural sedation, spasticity, narcolepsy, idiopathic hypersomnia, and postpartum depression. Major dosage forms include tablets, capsules, oral liquids, oral suspensions, injectable products, intravenous emulsions, nasal sprays, oromucosal products, and intrathecal injections. Upstream inputs mainly include active pharmaceutical ingredients, pharmaceutical excipients, emulsion oils, phospholipids, solubilizers, extended-release materials, sterile injectable components, drug-delivery devices, and pharmaceutical packaging. Downstream customers mainly include general hospitals, psychiatric hospitals, neurology departments, sleep medicine centers, epilepsy centers, operating rooms, rehabilitation institutions, specialty pharmacies, and pharmaceutical distributors. Competition is intense in mature oral generics, while neuroactive steroids, oxybate products, nasal sprays, complex intravenous emulsions, and intrathecal formulations retain higher added value, with an overall gross margin generally ranging from approximately 50% to 76%.
From the current market perspective, the GABA receptor modulator market consists of a large base of mature generic products and a smaller group of high-value innovative or differentiated medicines. Benzodiazepines, Z-drugs, barbiturates, midazolam, propofol, and baclofen have established clinical roles in anxiety, insomnia, epilepsy, anesthesia, sedation, and spasticity. Oxybate products, neuroactive steroids, remimazolam, and outpatient seizure-rescue products serve smaller patient populations but contribute disproportionately to market value.
Looking ahead, GABAA drug development will increasingly focus on receptor-subunit selectivity, extrasynaptic receptor modulation, neurosteroid binding sites, and mechanisms with lower dependence potential. The aim is to reduce next-day impairment, respiratory depression, cognitive effects, tolerance, and dependence. GABAB development will emphasize lower-sodium oxybate formulations, once-at-bedtime dosing, liquid baclofen products for pediatric and dysphagic patients, and intrathecal therapy for severe spasticity.
Key market drivers include the large patient populations affected by anxiety, insomnia, epilepsy, narcolepsy, idiopathic hypersomnia, multiple sclerosis, and spinal cord injury. Population aging, increasing surgical and endoscopic procedure volumes, improved sleep and mental health services, and greater rare-disease diagnosis support hospital and specialty-market demand. Low-sodium formulations, extended-release delivery, nasal administration, and neuroactive steroids are expanding the clinical scope of GABA-targeted therapies.
The main constraints include central nervous system depression, somnolence, cognitive and motor impairment, falls, respiratory depression, tolerance, dependence, misuse, and withdrawal. Benzodiazepines, Z-drugs, and oxybate products are subject to strict prescription and controlled-drug requirements, while oxybates also rely on restricted distribution systems. Generic competition, procurement pressure, insurance access, rebates, non-pharmacological treatment, and newer-mechanism medicines may limit growth in mature segments.
This report studies the global GABA Receptor Modulators demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for GABA Receptor Modulators, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of GABA Receptor Modulators that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global GABA Receptor Modulators total market, 2021-2032, (USD Million)
Global GABA Receptor Modulators total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: GABA Receptor Modulators total market, key domestic companies, and share, (USD Million)
Global GABA Receptor Modulators revenue by player, revenue and market share 2021-2026, (USD Million)
Global GABA Receptor Modulators total market by Type, CAGR, 2021-2032, (USD Million)
Global GABA Receptor Modulators total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global GABA Receptor Modulators market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pfizer, Viatris, Teva Pharmaceutical Industries, Sandoz, Hikma Pharmaceuticals, Fresenius Kabi, B. Braun, UCB, Neurelis, Eagle Pharmaceuticals, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world GABA Receptor Modulators market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global GABA Receptor Modulators Market, By Region:
1. How big is the global GABA Receptor Modulators market?
2. What is the demand of the global GABA Receptor Modulators market?
3. What is the year over year growth of the global GABA Receptor Modulators market?
4. What is the total value of the global GABA Receptor Modulators market?
5. Who are the Major Players in the global GABA Receptor Modulators market?
6. What are the growth factors driving the market demand?
GABA receptor modulators are prescription medicines that act directly on GABAA or GABAB receptors and alter inhibitory neurotransmission through agonism, positive allosteric modulation, or receptor antagonism. Commercial products mainly include benzodiazepines, Z-drug hypnotics, barbiturates, selected intravenous anesthetics and sedatives, neuroactive steroids, baclofen, and oxybate-based medicines. Clinical applications include anxiety disorders, insomnia, epilepsy and seizures, anesthesia and procedural sedation, spasticity, narcolepsy, idiopathic hypersomnia, and postpartum depression. Major dosage forms include tablets, capsules, oral liquids, oral suspensions, injectable products, intravenous emulsions, nasal sprays, oromucosal products, and intrathecal injections. Upstream inputs mainly include active pharmaceutical ingredients, pharmaceutical excipients, emulsion oils, phospholipids, solubilizers, extended-release materials, sterile injectable components, drug-delivery devices, and pharmaceutical packaging. Downstream customers mainly include general hospitals, psychiatric hospitals, neurology departments, sleep medicine centers, epilepsy centers, operating rooms, rehabilitation institutions, specialty pharmacies, and pharmaceutical distributors. Competition is intense in mature oral generics, while neuroactive steroids, oxybate products, nasal sprays, complex intravenous emulsions, and intrathecal formulations retain higher added value, with an overall gross margin generally ranging from approximately 50% to 76%.
From the current market perspective, the GABA receptor modulator market consists of a large base of mature generic products and a smaller group of high-value innovative or differentiated medicines. Benzodiazepines, Z-drugs, barbiturates, midazolam, propofol, and baclofen have established clinical roles in anxiety, insomnia, epilepsy, anesthesia, sedation, and spasticity. Oxybate products, neuroactive steroids, remimazolam, and outpatient seizure-rescue products serve smaller patient populations but contribute disproportionately to market value.
Looking ahead, GABAA drug development will increasingly focus on receptor-subunit selectivity, extrasynaptic receptor modulation, neurosteroid binding sites, and mechanisms with lower dependence potential. The aim is to reduce next-day impairment, respiratory depression, cognitive effects, tolerance, and dependence. GABAB development will emphasize lower-sodium oxybate formulations, once-at-bedtime dosing, liquid baclofen products for pediatric and dysphagic patients, and intrathecal therapy for severe spasticity.
Key market drivers include the large patient populations affected by anxiety, insomnia, epilepsy, narcolepsy, idiopathic hypersomnia, multiple sclerosis, and spinal cord injury. Population aging, increasing surgical and endoscopic procedure volumes, improved sleep and mental health services, and greater rare-disease diagnosis support hospital and specialty-market demand. Low-sodium formulations, extended-release delivery, nasal administration, and neuroactive steroids are expanding the clinical scope of GABA-targeted therapies.
The main constraints include central nervous system depression, somnolence, cognitive and motor impairment, falls, respiratory depression, tolerance, dependence, misuse, and withdrawal. Benzodiazepines, Z-drugs, and oxybate products are subject to strict prescription and controlled-drug requirements, while oxybates also rely on restricted distribution systems. Generic competition, procurement pressure, insurance access, rebates, non-pharmacological treatment, and newer-mechanism medicines may limit growth in mature segments.
This report studies the global GABA Receptor Modulators demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for GABA Receptor Modulators, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of GABA Receptor Modulators that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global GABA Receptor Modulators total market, 2021-2032, (USD Million)
Global GABA Receptor Modulators total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: GABA Receptor Modulators total market, key domestic companies, and share, (USD Million)
Global GABA Receptor Modulators revenue by player, revenue and market share 2021-2026, (USD Million)
Global GABA Receptor Modulators total market by Type, CAGR, 2021-2032, (USD Million)
Global GABA Receptor Modulators total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global GABA Receptor Modulators market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pfizer, Viatris, Teva Pharmaceutical Industries, Sandoz, Hikma Pharmaceuticals, Fresenius Kabi, B. Braun, UCB, Neurelis, Eagle Pharmaceuticals, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world GABA Receptor Modulators market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global GABA Receptor Modulators Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- GABAA Receptor Modulators
- GABAB Receptor Modulators
- Benzodiazepines
- Z-drugs
- Barbiturates
- Other
- Tablets and Capsules
- Oral Liquids and Suspensions
- Injectable Solutions
- Other
- Hospital
- Clinic
- Others
- Pfizer
- Viatris
- Teva Pharmaceutical Industries
- Sandoz
- Hikma Pharmaceuticals
- Fresenius Kabi
- B. Braun
- UCB
- Neurelis
- Eagle Pharmaceuticals
- Cosette Pharmaceuticals
- Supernus Pharmaceuticals
- Biogen
- Immedica Pharma
- Jazz Pharmaceuticals
- Alkermes
- Amneal Pharmaceuticals
- Azurity Pharmaceuticals
- Piramal Pharma
- Humanwell Healthcare Group
- Jiangsu Nhwa Pharmaceutical
1. How big is the global GABA Receptor Modulators market?
2. What is the demand of the global GABA Receptor Modulators market?
3. What is the year over year growth of the global GABA Receptor Modulators market?
4. What is the total value of the global GABA Receptor Modulators market?
5. Who are the Major Players in the global GABA Receptor Modulators market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 GABA Receptor Modulators Introduction
1.2 World GABA Receptor Modulators Market Size & Forecast (2021 & 2025 & 2032)
1.3 World GABA Receptor Modulators Total Market by Region (by Headquarter Location)
1.3.1 World GABA Receptor Modulators Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company GABA Receptor Modulators Revenue (2021-2032)
1.3.3 China Based Company GABA Receptor Modulators Revenue (2021-2032)
1.3.4 Europe Based Company GABA Receptor Modulators Revenue (2021-2032)
1.3.5 Japan Based Company GABA Receptor Modulators Revenue (2021-2032)
1.3.6 South Korea Based Company GABA Receptor Modulators Revenue (2021-2032)
1.3.7 ASEAN Based Company GABA Receptor Modulators Revenue (2021-2032)
1.3.8 India Based Company GABA Receptor Modulators Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 GABA Receptor Modulators Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World GABA Receptor Modulators Consumption Value (2021-2032)
2.2 World GABA Receptor Modulators Consumption Value by Region
2.2.1 World GABA Receptor Modulators Consumption Value by Region (2021-2026)
2.2.2 World GABA Receptor Modulators Consumption Value Forecast by Region (2027-2032)
2.3 United States GABA Receptor Modulators Consumption Value (2021-2032)
2.4 China GABA Receptor Modulators Consumption Value (2021-2032)
2.5 Europe GABA Receptor Modulators Consumption Value (2021-2032)
2.6 Japan GABA Receptor Modulators Consumption Value (2021-2032)
2.7 South Korea GABA Receptor Modulators Consumption Value (2021-2032)
2.8 ASEAN GABA Receptor Modulators Consumption Value (2021-2032)
2.9 India GABA Receptor Modulators Consumption Value (2021-2032)
3 WORLD GABA RECEPTOR MODULATORS COMPANIES COMPETITIVE ANALYSIS
3.1 World GABA Receptor Modulators Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global GABA Receptor Modulators Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for GABA Receptor Modulators in 2025
3.2.3 Global Concentration Ratios (CR8) for GABA Receptor Modulators in 2025
3.3 GABA Receptor Modulators Company Evaluation Quadrant
3.4 GABA Receptor Modulators Market: Overall Company Footprint Analysis
3.4.1 GABA Receptor Modulators Market: Region Footprint
3.4.2 GABA Receptor Modulators Market: Company Product Type Footprint
3.4.3 GABA Receptor Modulators Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: GABA Receptor Modulators Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: GABA Receptor Modulators Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: GABA Receptor Modulators Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: GABA Receptor Modulators Consumption Value Comparison
4.2.1 United States VS China: GABA Receptor Modulators Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: GABA Receptor Modulators Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based GABA Receptor Modulators Companies and Market Share, 2021-2026
4.3.1 United States Based GABA Receptor Modulators Companies, Headquarters (States, Country)
4.3.2 United States Based Companies GABA Receptor Modulators Revenue, (2021-2026)
4.4 China Based Companies GABA Receptor Modulators Revenue and Market Share, 2021-2026
4.4.1 China Based GABA Receptor Modulators Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies GABA Receptor Modulators Revenue, (2021-2026)
4.5 Rest of World Based GABA Receptor Modulators Companies and Market Share, 2021-2026
4.5.1 Rest of World Based GABA Receptor Modulators Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies GABA Receptor Modulators Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World GABA Receptor Modulators Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 GABAA Receptor Modulators
5.2.2 GABAB Receptor Modulators
5.3 Market Segment by Type
5.3.1 World GABA Receptor Modulators Market Size by Type (2021-2026)
5.3.2 World GABA Receptor Modulators Market Size by Type (2027-2032)
5.3.3 World GABA Receptor Modulators Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY PHARMACOLOGICAL CLASS
6.1 World GABA Receptor Modulators Market Size Overview by Pharmacological Class: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Pharmacological Class
6.2.1 Benzodiazepines
6.2.2 Z-drugs
6.2.3 Barbiturates
6.2.4 Other
6.3 Market Segment by Pharmacological Class
6.3.1 World GABA Receptor Modulators Market Size by Pharmacological Class (2021-2026)
6.3.2 World GABA Receptor Modulators Market Size by Pharmacological Class (2027-2032)
6.3.3 World GABA Receptor Modulators Market Size Market Share by Pharmacological Class (2027-2032)
7 MARKET ANALYSIS BY DOSAGE FORM
7.1 World GABA Receptor Modulators Market Size Overview by Dosage Form: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Dosage Form
7.2.1 Tablets and Capsules
7.2.2 Oral Liquids and Suspensions
7.2.3 Injectable Solutions
7.2.4 Other
7.3 Market Segment by Dosage Form
7.3.1 World GABA Receptor Modulators Market Size by Dosage Form (2021-2026)
7.3.2 World GABA Receptor Modulators Market Size by Dosage Form (2027-2032)
7.3.3 World GABA Receptor Modulators Market Size Market Share by Dosage Form (2027-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World GABA Receptor Modulators Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Hospital
8.2.2 Clinic
8.2.3 Others
8.3 Market Segment by Application
8.3.1 World GABA Receptor Modulators Market Size by Application (2021-2026)
8.3.2 World GABA Receptor Modulators Market Size by Application (2027-2032)
8.3.3 World GABA Receptor Modulators Market Size Market Share by Application (2021-2032)
9 COMPANY PROFILES
9.1 Pfizer
9.1.1 Pfizer Details
9.1.2 Pfizer Major Business
9.1.3 Pfizer GABA Receptor Modulators Product and Services
9.1.4 Pfizer GABA Receptor Modulators Revenue, Gross Margin and Market Share (2021-2026)
9.1.5 Pfizer Recent Developments/Updates
9.1.6 Pfizer Competitive Strengths & Weaknesses
9.2 Viatris
9.2.1 Viatris Details
9.2.2 Viatris Major Business
9.2.3 Viatris GABA Receptor Modulators Product and Services
9.2.4 Viatris GABA Receptor Modulators Revenue, Gross Margin and Market Share (2021-2026)
9.2.5 Viatris Recent Developments/Updates
9.2.6 Viatris Competitive Strengths & Weaknesses
9.3 Teva Pharmaceutical Industries
9.3.1 Teva Pharmaceutical Industries Details
9.3.2 Teva Pharmaceutical Industries Major Business
9.3.3 Teva Pharmaceutical Industries GABA Receptor Modulators Product and Services
9.3.4 Teva Pharmaceutical Industries GABA Receptor Modulators Revenue, Gross Margin and Market Share (2021-2026)
9.3.5 Teva Pharmaceutical Industries Recent Developments/Updates
9.3.6 Teva Pharmaceutical Industries Competitive Strengths & Weaknesses
9.4 Sandoz
9.4.1 Sandoz Details
9.4.2 Sandoz Major Business
9.4.3 Sandoz GABA Receptor Modulators Product and Services
9.4.4 Sandoz GABA Receptor Modulators Revenue, Gross Margin and Market Share (2021-2026)
9.4.5 Sandoz Recent Developments/Updates
9.4.6 Sandoz Competitive Strengths & Weaknesses
9.5 Hikma Pharmaceuticals
9.5.1 Hikma Pharmaceuticals Details
9.5.2 Hikma Pharmaceuticals Major Business
9.5.3 Hikma Pharmaceuticals GABA Receptor Modulators Product and Services
9.5.4 Hikma Pharmaceuticals GABA Receptor Modulators Revenue, Gross Margin and Market Share (2021-2026)
9.5.5 Hikma Pharmaceuticals Recent Developments/Updates
9.5.6 Hikma Pharmaceuticals Competitive Strengths & Weaknesses
9.6 Fresenius Kabi
9.6.1 Fresenius Kabi Details
9.6.2 Fresenius Kabi Major Business
9.6.3 Fresenius Kabi GABA Receptor Modulators Product and Services
9.6.4 Fresenius Kabi GABA Receptor Modulators Revenue, Gross Margin and Market Share (2021-2026)
9.6.5 Fresenius Kabi Recent Developments/Updates
9.6.6 Fresenius Kabi Competitive Strengths & Weaknesses
9.7 B. Braun
9.7.1 B. Braun Details
9.7.2 B. Braun Major Business
9.7.3 B. Braun GABA Receptor Modulators Product and Services
9.7.4 B. Braun GABA Receptor Modulators Revenue, Gross Margin and Market Share (2021-2026)
9.7.5 B. Braun Recent Developments/Updates
9.7.6 B. Braun Competitive Strengths & Weaknesses
9.8 UCB
9.8.1 UCB Details
9.8.2 UCB Major Business
9.8.3 UCB GABA Receptor Modulators Product and Services
9.8.4 UCB GABA Receptor Modulators Revenue, Gross Margin and Market Share (2021-2026)
9.8.5 UCB Recent Developments/Updates
9.8.6 UCB Competitive Strengths & Weaknesses
9.9 Neurelis
9.9.1 Neurelis Details
9.9.2 Neurelis Major Business
9.9.3 Neurelis GABA Receptor Modulators Product and Services
9.9.4 Neurelis GABA Receptor Modulators Revenue, Gross Margin and Market Share (2021-2026)
9.9.5 Neurelis Recent Developments/Updates
9.9.6 Neurelis Competitive Strengths & Weaknesses
9.10 Eagle Pharmaceuticals
9.10.1 Eagle Pharmaceuticals Details
9.10.2 Eagle Pharmaceuticals Major Business
9.10.3 Eagle Pharmaceuticals GABA Receptor Modulators Product and Services
9.10.4 Eagle Pharmaceuticals GABA Receptor Modulators Revenue, Gross Margin and Market Share (2021-2026)
9.10.5 Eagle Pharmaceuticals Recent Developments/Updates
9.10.6 Eagle Pharmaceuticals Competitive Strengths & Weaknesses
9.11 Cosette Pharmaceuticals
9.11.1 Cosette Pharmaceuticals Details
9.11.2 Cosette Pharmaceuticals Major Business
9.11.3 Cosette Pharmaceuticals GABA Receptor Modulators Product and Services
9.11.4 Cosette Pharmaceuticals GABA Receptor Modulators Revenue, Gross Margin and Market Share (2021-2026)
9.11.5 Cosette Pharmaceuticals Recent Developments/Updates
9.11.6 Cosette Pharmaceuticals Competitive Strengths & Weaknesses
9.12 Supernus Pharmaceuticals
9.12.1 Supernus Pharmaceuticals Details
9.12.2 Supernus Pharmaceuticals Major Business
9.12.3 Supernus Pharmaceuticals GABA Receptor Modulators Product and Services
9.12.4 Supernus Pharmaceuticals GABA Receptor Modulators Revenue, Gross Margin and Market Share (2021-2026)
9.12.5 Supernus Pharmaceuticals Recent Developments/Updates
9.12.6 Supernus Pharmaceuticals Competitive Strengths & Weaknesses
9.13 Biogen
9.13.1 Biogen Details
9.13.2 Biogen Major Business
9.13.3 Biogen GABA Receptor Modulators Product and Services
9.13.4 Biogen GABA Receptor Modulators Revenue, Gross Margin and Market Share (2021-2026)
9.13.5 Biogen Recent Developments/Updates
9.13.6 Biogen Competitive Strengths & Weaknesses
9.14 Immedica Pharma
9.14.1 Immedica Pharma Details
9.14.2 Immedica Pharma Major Business
9.14.3 Immedica Pharma GABA Receptor Modulators Product and Services
9.14.4 Immedica Pharma GABA Receptor Modulators Revenue, Gross Margin and Market Share (2021-2026)
9.14.5 Immedica Pharma Recent Developments/Updates
9.14.6 Immedica Pharma Competitive Strengths & Weaknesses
9.15 Jazz Pharmaceuticals
9.15.1 Jazz Pharmaceuticals Details
9.15.2 Jazz Pharmaceuticals Major Business
9.15.3 Jazz Pharmaceuticals GABA Receptor Modulators Product and Services
9.15.4 Jazz Pharmaceuticals GABA Receptor Modulators Revenue, Gross Margin and Market Share (2021-2026)
9.15.5 Jazz Pharmaceuticals Recent Developments/Updates
9.15.6 Jazz Pharmaceuticals Competitive Strengths & Weaknesses
9.16 Alkermes
9.16.1 Alkermes Details
9.16.2 Alkermes Major Business
9.16.3 Alkermes GABA Receptor Modulators Product and Services
9.16.4 Alkermes GABA Receptor Modulators Revenue, Gross Margin and Market Share (2021-2026)
9.16.5 Alkermes Recent Developments/Updates
9.16.6 Alkermes Competitive Strengths & Weaknesses
9.17 Amneal Pharmaceuticals
9.17.1 Amneal Pharmaceuticals Details
9.17.2 Amneal Pharmaceuticals Major Business
9.17.3 Amneal Pharmaceuticals GABA Receptor Modulators Product and Services
9.17.4 Amneal Pharmaceuticals GABA Receptor Modulators Revenue, Gross Margin and Market Share (2021-2026)
9.17.5 Amneal Pharmaceuticals Recent Developments/Updates
9.17.6 Amneal Pharmaceuticals Competitive Strengths & Weaknesses
9.18 Azurity Pharmaceuticals
9.18.1 Azurity Pharmaceuticals Details
9.18.2 Azurity Pharmaceuticals Major Business
9.18.3 Azurity Pharmaceuticals GABA Receptor Modulators Product and Services
9.18.4 Azurity Pharmaceuticals GABA Receptor Modulators Revenue, Gross Margin and Market Share (2021-2026)
9.18.5 Azurity Pharmaceuticals Recent Developments/Updates
9.18.6 Azurity Pharmaceuticals Competitive Strengths & Weaknesses
9.19 Piramal Pharma
9.19.1 Piramal Pharma Details
9.19.2 Piramal Pharma Major Business
9.19.3 Piramal Pharma GABA Receptor Modulators Product and Services
9.19.4 Piramal Pharma GABA Receptor Modulators Revenue, Gross Margin and Market Share (2021-2026)
9.19.5 Piramal Pharma Recent Developments/Updates
9.19.6 Piramal Pharma Competitive Strengths & Weaknesses
9.20 Humanwell Healthcare Group
9.20.1 Humanwell Healthcare Group Details
9.20.2 Humanwell Healthcare Group Major Business
9.20.3 Humanwell Healthcare Group GABA Receptor Modulators Product and Services
9.20.4 Humanwell Healthcare Group GABA Receptor Modulators Revenue, Gross Margin and Market Share (2021-2026)
9.20.5 Humanwell Healthcare Group Recent Developments/Updates
9.20.6 Humanwell Healthcare Group Competitive Strengths & Weaknesses
9.21 Jiangsu Nhwa Pharmaceutical
9.21.1 Jiangsu Nhwa Pharmaceutical Details
9.21.2 Jiangsu Nhwa Pharmaceutical Major Business
9.21.3 Jiangsu Nhwa Pharmaceutical GABA Receptor Modulators Product and Services
9.21.4 Jiangsu Nhwa Pharmaceutical GABA Receptor Modulators Revenue, Gross Margin and Market Share (2021-2026)
9.21.5 Jiangsu Nhwa Pharmaceutical Recent Developments/Updates
9.21.6 Jiangsu Nhwa Pharmaceutical Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 GABA Receptor Modulators Industry Chain
10.2 GABA Receptor Modulators Upstream Analysis
10.3 GABA Receptor Modulators Midstream Analysis
10.4 GABA Receptor Modulators Downstream Analysis
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
1.1 GABA Receptor Modulators Introduction
1.2 World GABA Receptor Modulators Market Size & Forecast (2021 & 2025 & 2032)
1.3 World GABA Receptor Modulators Total Market by Region (by Headquarter Location)
1.3.1 World GABA Receptor Modulators Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company GABA Receptor Modulators Revenue (2021-2032)
1.3.3 China Based Company GABA Receptor Modulators Revenue (2021-2032)
1.3.4 Europe Based Company GABA Receptor Modulators Revenue (2021-2032)
1.3.5 Japan Based Company GABA Receptor Modulators Revenue (2021-2032)
1.3.6 South Korea Based Company GABA Receptor Modulators Revenue (2021-2032)
1.3.7 ASEAN Based Company GABA Receptor Modulators Revenue (2021-2032)
1.3.8 India Based Company GABA Receptor Modulators Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 GABA Receptor Modulators Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World GABA Receptor Modulators Consumption Value (2021-2032)
2.2 World GABA Receptor Modulators Consumption Value by Region
2.2.1 World GABA Receptor Modulators Consumption Value by Region (2021-2026)
2.2.2 World GABA Receptor Modulators Consumption Value Forecast by Region (2027-2032)
2.3 United States GABA Receptor Modulators Consumption Value (2021-2032)
2.4 China GABA Receptor Modulators Consumption Value (2021-2032)
2.5 Europe GABA Receptor Modulators Consumption Value (2021-2032)
2.6 Japan GABA Receptor Modulators Consumption Value (2021-2032)
2.7 South Korea GABA Receptor Modulators Consumption Value (2021-2032)
2.8 ASEAN GABA Receptor Modulators Consumption Value (2021-2032)
2.9 India GABA Receptor Modulators Consumption Value (2021-2032)
3 WORLD GABA RECEPTOR MODULATORS COMPANIES COMPETITIVE ANALYSIS
3.1 World GABA Receptor Modulators Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global GABA Receptor Modulators Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for GABA Receptor Modulators in 2025
3.2.3 Global Concentration Ratios (CR8) for GABA Receptor Modulators in 2025
3.3 GABA Receptor Modulators Company Evaluation Quadrant
3.4 GABA Receptor Modulators Market: Overall Company Footprint Analysis
3.4.1 GABA Receptor Modulators Market: Region Footprint
3.4.2 GABA Receptor Modulators Market: Company Product Type Footprint
3.4.3 GABA Receptor Modulators Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: GABA Receptor Modulators Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: GABA Receptor Modulators Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: GABA Receptor Modulators Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: GABA Receptor Modulators Consumption Value Comparison
4.2.1 United States VS China: GABA Receptor Modulators Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: GABA Receptor Modulators Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based GABA Receptor Modulators Companies and Market Share, 2021-2026
4.3.1 United States Based GABA Receptor Modulators Companies, Headquarters (States, Country)
4.3.2 United States Based Companies GABA Receptor Modulators Revenue, (2021-2026)
4.4 China Based Companies GABA Receptor Modulators Revenue and Market Share, 2021-2026
4.4.1 China Based GABA Receptor Modulators Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies GABA Receptor Modulators Revenue, (2021-2026)
4.5 Rest of World Based GABA Receptor Modulators Companies and Market Share, 2021-2026
4.5.1 Rest of World Based GABA Receptor Modulators Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies GABA Receptor Modulators Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World GABA Receptor Modulators Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 GABAA Receptor Modulators
5.2.2 GABAB Receptor Modulators
5.3 Market Segment by Type
5.3.1 World GABA Receptor Modulators Market Size by Type (2021-2026)
5.3.2 World GABA Receptor Modulators Market Size by Type (2027-2032)
5.3.3 World GABA Receptor Modulators Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY PHARMACOLOGICAL CLASS
6.1 World GABA Receptor Modulators Market Size Overview by Pharmacological Class: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Pharmacological Class
6.2.1 Benzodiazepines
6.2.2 Z-drugs
6.2.3 Barbiturates
6.2.4 Other
6.3 Market Segment by Pharmacological Class
6.3.1 World GABA Receptor Modulators Market Size by Pharmacological Class (2021-2026)
6.3.2 World GABA Receptor Modulators Market Size by Pharmacological Class (2027-2032)
6.3.3 World GABA Receptor Modulators Market Size Market Share by Pharmacological Class (2027-2032)
7 MARKET ANALYSIS BY DOSAGE FORM
7.1 World GABA Receptor Modulators Market Size Overview by Dosage Form: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Dosage Form
7.2.1 Tablets and Capsules
7.2.2 Oral Liquids and Suspensions
7.2.3 Injectable Solutions
7.2.4 Other
7.3 Market Segment by Dosage Form
7.3.1 World GABA Receptor Modulators Market Size by Dosage Form (2021-2026)
7.3.2 World GABA Receptor Modulators Market Size by Dosage Form (2027-2032)
7.3.3 World GABA Receptor Modulators Market Size Market Share by Dosage Form (2027-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World GABA Receptor Modulators Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Hospital
8.2.2 Clinic
8.2.3 Others
8.3 Market Segment by Application
8.3.1 World GABA Receptor Modulators Market Size by Application (2021-2026)
8.3.2 World GABA Receptor Modulators Market Size by Application (2027-2032)
8.3.3 World GABA Receptor Modulators Market Size Market Share by Application (2021-2032)
9 COMPANY PROFILES
9.1 Pfizer
9.1.1 Pfizer Details
9.1.2 Pfizer Major Business
9.1.3 Pfizer GABA Receptor Modulators Product and Services
9.1.4 Pfizer GABA Receptor Modulators Revenue, Gross Margin and Market Share (2021-2026)
9.1.5 Pfizer Recent Developments/Updates
9.1.6 Pfizer Competitive Strengths & Weaknesses
9.2 Viatris
9.2.1 Viatris Details
9.2.2 Viatris Major Business
9.2.3 Viatris GABA Receptor Modulators Product and Services
9.2.4 Viatris GABA Receptor Modulators Revenue, Gross Margin and Market Share (2021-2026)
9.2.5 Viatris Recent Developments/Updates
9.2.6 Viatris Competitive Strengths & Weaknesses
9.3 Teva Pharmaceutical Industries
9.3.1 Teva Pharmaceutical Industries Details
9.3.2 Teva Pharmaceutical Industries Major Business
9.3.3 Teva Pharmaceutical Industries GABA Receptor Modulators Product and Services
9.3.4 Teva Pharmaceutical Industries GABA Receptor Modulators Revenue, Gross Margin and Market Share (2021-2026)
9.3.5 Teva Pharmaceutical Industries Recent Developments/Updates
9.3.6 Teva Pharmaceutical Industries Competitive Strengths & Weaknesses
9.4 Sandoz
9.4.1 Sandoz Details
9.4.2 Sandoz Major Business
9.4.3 Sandoz GABA Receptor Modulators Product and Services
9.4.4 Sandoz GABA Receptor Modulators Revenue, Gross Margin and Market Share (2021-2026)
9.4.5 Sandoz Recent Developments/Updates
9.4.6 Sandoz Competitive Strengths & Weaknesses
9.5 Hikma Pharmaceuticals
9.5.1 Hikma Pharmaceuticals Details
9.5.2 Hikma Pharmaceuticals Major Business
9.5.3 Hikma Pharmaceuticals GABA Receptor Modulators Product and Services
9.5.4 Hikma Pharmaceuticals GABA Receptor Modulators Revenue, Gross Margin and Market Share (2021-2026)
9.5.5 Hikma Pharmaceuticals Recent Developments/Updates
9.5.6 Hikma Pharmaceuticals Competitive Strengths & Weaknesses
9.6 Fresenius Kabi
9.6.1 Fresenius Kabi Details
9.6.2 Fresenius Kabi Major Business
9.6.3 Fresenius Kabi GABA Receptor Modulators Product and Services
9.6.4 Fresenius Kabi GABA Receptor Modulators Revenue, Gross Margin and Market Share (2021-2026)
9.6.5 Fresenius Kabi Recent Developments/Updates
9.6.6 Fresenius Kabi Competitive Strengths & Weaknesses
9.7 B. Braun
9.7.1 B. Braun Details
9.7.2 B. Braun Major Business
9.7.3 B. Braun GABA Receptor Modulators Product and Services
9.7.4 B. Braun GABA Receptor Modulators Revenue, Gross Margin and Market Share (2021-2026)
9.7.5 B. Braun Recent Developments/Updates
9.7.6 B. Braun Competitive Strengths & Weaknesses
9.8 UCB
9.8.1 UCB Details
9.8.2 UCB Major Business
9.8.3 UCB GABA Receptor Modulators Product and Services
9.8.4 UCB GABA Receptor Modulators Revenue, Gross Margin and Market Share (2021-2026)
9.8.5 UCB Recent Developments/Updates
9.8.6 UCB Competitive Strengths & Weaknesses
9.9 Neurelis
9.9.1 Neurelis Details
9.9.2 Neurelis Major Business
9.9.3 Neurelis GABA Receptor Modulators Product and Services
9.9.4 Neurelis GABA Receptor Modulators Revenue, Gross Margin and Market Share (2021-2026)
9.9.5 Neurelis Recent Developments/Updates
9.9.6 Neurelis Competitive Strengths & Weaknesses
9.10 Eagle Pharmaceuticals
9.10.1 Eagle Pharmaceuticals Details
9.10.2 Eagle Pharmaceuticals Major Business
9.10.3 Eagle Pharmaceuticals GABA Receptor Modulators Product and Services
9.10.4 Eagle Pharmaceuticals GABA Receptor Modulators Revenue, Gross Margin and Market Share (2021-2026)
9.10.5 Eagle Pharmaceuticals Recent Developments/Updates
9.10.6 Eagle Pharmaceuticals Competitive Strengths & Weaknesses
9.11 Cosette Pharmaceuticals
9.11.1 Cosette Pharmaceuticals Details
9.11.2 Cosette Pharmaceuticals Major Business
9.11.3 Cosette Pharmaceuticals GABA Receptor Modulators Product and Services
9.11.4 Cosette Pharmaceuticals GABA Receptor Modulators Revenue, Gross Margin and Market Share (2021-2026)
9.11.5 Cosette Pharmaceuticals Recent Developments/Updates
9.11.6 Cosette Pharmaceuticals Competitive Strengths & Weaknesses
9.12 Supernus Pharmaceuticals
9.12.1 Supernus Pharmaceuticals Details
9.12.2 Supernus Pharmaceuticals Major Business
9.12.3 Supernus Pharmaceuticals GABA Receptor Modulators Product and Services
9.12.4 Supernus Pharmaceuticals GABA Receptor Modulators Revenue, Gross Margin and Market Share (2021-2026)
9.12.5 Supernus Pharmaceuticals Recent Developments/Updates
9.12.6 Supernus Pharmaceuticals Competitive Strengths & Weaknesses
9.13 Biogen
9.13.1 Biogen Details
9.13.2 Biogen Major Business
9.13.3 Biogen GABA Receptor Modulators Product and Services
9.13.4 Biogen GABA Receptor Modulators Revenue, Gross Margin and Market Share (2021-2026)
9.13.5 Biogen Recent Developments/Updates
9.13.6 Biogen Competitive Strengths & Weaknesses
9.14 Immedica Pharma
9.14.1 Immedica Pharma Details
9.14.2 Immedica Pharma Major Business
9.14.3 Immedica Pharma GABA Receptor Modulators Product and Services
9.14.4 Immedica Pharma GABA Receptor Modulators Revenue, Gross Margin and Market Share (2021-2026)
9.14.5 Immedica Pharma Recent Developments/Updates
9.14.6 Immedica Pharma Competitive Strengths & Weaknesses
9.15 Jazz Pharmaceuticals
9.15.1 Jazz Pharmaceuticals Details
9.15.2 Jazz Pharmaceuticals Major Business
9.15.3 Jazz Pharmaceuticals GABA Receptor Modulators Product and Services
9.15.4 Jazz Pharmaceuticals GABA Receptor Modulators Revenue, Gross Margin and Market Share (2021-2026)
9.15.5 Jazz Pharmaceuticals Recent Developments/Updates
9.15.6 Jazz Pharmaceuticals Competitive Strengths & Weaknesses
9.16 Alkermes
9.16.1 Alkermes Details
9.16.2 Alkermes Major Business
9.16.3 Alkermes GABA Receptor Modulators Product and Services
9.16.4 Alkermes GABA Receptor Modulators Revenue, Gross Margin and Market Share (2021-2026)
9.16.5 Alkermes Recent Developments/Updates
9.16.6 Alkermes Competitive Strengths & Weaknesses
9.17 Amneal Pharmaceuticals
9.17.1 Amneal Pharmaceuticals Details
9.17.2 Amneal Pharmaceuticals Major Business
9.17.3 Amneal Pharmaceuticals GABA Receptor Modulators Product and Services
9.17.4 Amneal Pharmaceuticals GABA Receptor Modulators Revenue, Gross Margin and Market Share (2021-2026)
9.17.5 Amneal Pharmaceuticals Recent Developments/Updates
9.17.6 Amneal Pharmaceuticals Competitive Strengths & Weaknesses
9.18 Azurity Pharmaceuticals
9.18.1 Azurity Pharmaceuticals Details
9.18.2 Azurity Pharmaceuticals Major Business
9.18.3 Azurity Pharmaceuticals GABA Receptor Modulators Product and Services
9.18.4 Azurity Pharmaceuticals GABA Receptor Modulators Revenue, Gross Margin and Market Share (2021-2026)
9.18.5 Azurity Pharmaceuticals Recent Developments/Updates
9.18.6 Azurity Pharmaceuticals Competitive Strengths & Weaknesses
9.19 Piramal Pharma
9.19.1 Piramal Pharma Details
9.19.2 Piramal Pharma Major Business
9.19.3 Piramal Pharma GABA Receptor Modulators Product and Services
9.19.4 Piramal Pharma GABA Receptor Modulators Revenue, Gross Margin and Market Share (2021-2026)
9.19.5 Piramal Pharma Recent Developments/Updates
9.19.6 Piramal Pharma Competitive Strengths & Weaknesses
9.20 Humanwell Healthcare Group
9.20.1 Humanwell Healthcare Group Details
9.20.2 Humanwell Healthcare Group Major Business
9.20.3 Humanwell Healthcare Group GABA Receptor Modulators Product and Services
9.20.4 Humanwell Healthcare Group GABA Receptor Modulators Revenue, Gross Margin and Market Share (2021-2026)
9.20.5 Humanwell Healthcare Group Recent Developments/Updates
9.20.6 Humanwell Healthcare Group Competitive Strengths & Weaknesses
9.21 Jiangsu Nhwa Pharmaceutical
9.21.1 Jiangsu Nhwa Pharmaceutical Details
9.21.2 Jiangsu Nhwa Pharmaceutical Major Business
9.21.3 Jiangsu Nhwa Pharmaceutical GABA Receptor Modulators Product and Services
9.21.4 Jiangsu Nhwa Pharmaceutical GABA Receptor Modulators Revenue, Gross Margin and Market Share (2021-2026)
9.21.5 Jiangsu Nhwa Pharmaceutical Recent Developments/Updates
9.21.6 Jiangsu Nhwa Pharmaceutical Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 GABA Receptor Modulators Industry Chain
10.2 GABA Receptor Modulators Upstream Analysis
10.3 GABA Receptor Modulators Midstream Analysis
10.4 GABA Receptor Modulators Downstream Analysis
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
LIST OF TABLES
Table 1. World GABA Receptor Modulators Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World GABA Receptor Modulators Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World GABA Receptor Modulators Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World GABA Receptor Modulators Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World GABA Receptor Modulators Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World GABA Receptor Modulators Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World GABA Receptor Modulators Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World GABA Receptor Modulators Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World GABA Receptor Modulators Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key GABA Receptor Modulators Players in 2025
Table 12. World GABA Receptor Modulators Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global GABA Receptor Modulators Company Evaluation Quadrant
Table 14. Head Office of Key GABA Receptor Modulators Players
Table 15. GABA Receptor Modulators Market: Company Product Type Footprint
Table 16. GABA Receptor Modulators Market: Company Product Application Footprint
Table 17. GABA Receptor Modulators Mergers & Acquisitions Activity
Table 18. United States VS China GABA Receptor Modulators Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China GABA Receptor Modulators Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based GABA Receptor Modulators Companies, Headquarters (States, Country)
Table 21. United States Based Companies GABA Receptor Modulators Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies GABA Receptor Modulators Revenue Market Share (2021-2026)
Table 23. China Based GABA Receptor Modulators Companies, Headquarters (Province, Country)
Table 24. China Based Companies GABA Receptor Modulators Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies GABA Receptor Modulators Revenue Market Share (2021-2026)
Table 26. Rest of World Based GABA Receptor Modulators Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies GABA Receptor Modulators Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies GABA Receptor Modulators Revenue Market Share (2021-2026)
Table 29. World GABA Receptor Modulators Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World GABA Receptor Modulators Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World GABA Receptor Modulators Market Size by Type (2027-2032) & (USD Million)
Table 32. World GABA Receptor Modulators Market Size by Pharmacological Class, (USD Million), 2021 & 2025 & 2032
Table 33. World GABA Receptor Modulators Market Size Value by Pharmacological Class (2021-2026) & (USD Million)
Table 34. World GABA Receptor Modulators Market Size by Pharmacological Class (2027-2032) & (USD Million)
Table 35. World GABA Receptor Modulators Market Size by Dosage Form, (USD Million), 2021 & 2025 & 2032
Table 36. World GABA Receptor Modulators Market Size Value by Dosage Form (2021-2026) & (USD Million)
Table 37. World GABA Receptor Modulators Market Size by Dosage Form (2027-2032) & (USD Million)
Table 38. World GABA Receptor Modulators Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 39. World GABA Receptor Modulators Market Size by Application (2021-2026) & (USD Million)
Table 40. World GABA Receptor Modulators Market Size by Application (2027-2032) & (USD Million)
Table 41. Pfizer Basic Information, Manufacturing Base and Competitors
Table 42. Pfizer Major Business
Table 43. Pfizer GABA Receptor Modulators Product and Services
Table 44. Pfizer GABA Receptor Modulators Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. Pfizer Recent Developments/Updates
Table 46. Pfizer Competitive Strengths & Weaknesses
Table 47. Viatris Basic Information, Manufacturing Base and Competitors
Table 48. Viatris Major Business
Table 49. Viatris GABA Receptor Modulators Product and Services
Table 50. Viatris GABA Receptor Modulators Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. Viatris Recent Developments/Updates
Table 52. Viatris Competitive Strengths & Weaknesses
Table 53. Teva Pharmaceutical Industries Basic Information, Manufacturing Base and Competitors
Table 54. Teva Pharmaceutical Industries Major Business
Table 55. Teva Pharmaceutical Industries GABA Receptor Modulators Product and Services
Table 56. Teva Pharmaceutical Industries GABA Receptor Modulators Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. Teva Pharmaceutical Industries Recent Developments/Updates
Table 58. Teva Pharmaceutical Industries Competitive Strengths & Weaknesses
Table 59. Sandoz Basic Information, Manufacturing Base and Competitors
Table 60. Sandoz Major Business
Table 61. Sandoz GABA Receptor Modulators Product and Services
Table 62. Sandoz GABA Receptor Modulators Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. Sandoz Recent Developments/Updates
Table 64. Sandoz Competitive Strengths & Weaknesses
Table 65. Hikma Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 66. Hikma Pharmaceuticals Major Business
Table 67. Hikma Pharmaceuticals GABA Receptor Modulators Product and Services
Table 68. Hikma Pharmaceuticals GABA Receptor Modulators Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. Hikma Pharmaceuticals Recent Developments/Updates
Table 70. Hikma Pharmaceuticals Competitive Strengths & Weaknesses
Table 71. Fresenius Kabi Basic Information, Manufacturing Base and Competitors
Table 72. Fresenius Kabi Major Business
Table 73. Fresenius Kabi GABA Receptor Modulators Product and Services
Table 74. Fresenius Kabi GABA Receptor Modulators Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. Fresenius Kabi Recent Developments/Updates
Table 76. Fresenius Kabi Competitive Strengths & Weaknesses
Table 77. B. Braun Basic Information, Manufacturing Base and Competitors
Table 78. B. Braun Major Business
Table 79. B. Braun GABA Receptor Modulators Product and Services
Table 80. B. Braun GABA Receptor Modulators Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. B. Braun Recent Developments/Updates
Table 82. B. Braun Competitive Strengths & Weaknesses
Table 83. UCB Basic Information, Manufacturing Base and Competitors
Table 84. UCB Major Business
Table 85. UCB GABA Receptor Modulators Product and Services
Table 86. UCB GABA Receptor Modulators Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. UCB Recent Developments/Updates
Table 88. UCB Competitive Strengths & Weaknesses
Table 89. Neurelis Basic Information, Manufacturing Base and Competitors
Table 90. Neurelis Major Business
Table 91. Neurelis GABA Receptor Modulators Product and Services
Table 92. Neurelis GABA Receptor Modulators Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. Neurelis Recent Developments/Updates
Table 94. Neurelis Competitive Strengths & Weaknesses
Table 95. Eagle Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 96. Eagle Pharmaceuticals Major Business
Table 97. Eagle Pharmaceuticals GABA Receptor Modulators Product and Services
Table 98. Eagle Pharmaceuticals GABA Receptor Modulators Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. Eagle Pharmaceuticals Recent Developments/Updates
Table 100. Eagle Pharmaceuticals Competitive Strengths & Weaknesses
Table 101. Cosette Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 102. Cosette Pharmaceuticals Major Business
Table 103. Cosette Pharmaceuticals GABA Receptor Modulators Product and Services
Table 104. Cosette Pharmaceuticals GABA Receptor Modulators Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. Cosette Pharmaceuticals Recent Developments/Updates
Table 106. Cosette Pharmaceuticals Competitive Strengths & Weaknesses
Table 107. Supernus Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 108. Supernus Pharmaceuticals Major Business
Table 109. Supernus Pharmaceuticals GABA Receptor Modulators Product and Services
Table 110. Supernus Pharmaceuticals GABA Receptor Modulators Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 111. Supernus Pharmaceuticals Recent Developments/Updates
Table 112. Supernus Pharmaceuticals Competitive Strengths & Weaknesses
Table 113. Biogen Basic Information, Manufacturing Base and Competitors
Table 114. Biogen Major Business
Table 115. Biogen GABA Receptor Modulators Product and Services
Table 116. Biogen GABA Receptor Modulators Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 117. Biogen Recent Developments/Updates
Table 118. Biogen Competitive Strengths & Weaknesses
Table 119. Immedica Pharma Basic Information, Manufacturing Base and Competitors
Table 120. Immedica Pharma Major Business
Table 121. Immedica Pharma GABA Receptor Modulators Product and Services
Table 122. Immedica Pharma GABA Receptor Modulators Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 123. Immedica Pharma Recent Developments/Updates
Table 124. Immedica Pharma Competitive Strengths & Weaknesses
Table 125. Jazz Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 126. Jazz Pharmaceuticals Major Business
Table 127. Jazz Pharmaceuticals GABA Receptor Modulators Product and Services
Table 128. Jazz Pharmaceuticals GABA Receptor Modulators Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 129. Jazz Pharmaceuticals Recent Developments/Updates
Table 130. Jazz Pharmaceuticals Competitive Strengths & Weaknesses
Table 131. Alkermes Basic Information, Manufacturing Base and Competitors
Table 132. Alkermes Major Business
Table 133. Alkermes GABA Receptor Modulators Product and Services
Table 134. Alkermes GABA Receptor Modulators Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 135. Alkermes Recent Developments/Updates
Table 136. Alkermes Competitive Strengths & Weaknesses
Table 137. Amneal Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 138. Amneal Pharmaceuticals Major Business
Table 139. Amneal Pharmaceuticals GABA Receptor Modulators Product and Services
Table 140. Amneal Pharmaceuticals GABA Receptor Modulators Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 141. Amneal Pharmaceuticals Recent Developments/Updates
Table 142. Amneal Pharmaceuticals Competitive Strengths & Weaknesses
Table 143. Azurity Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 144. Azurity Pharmaceuticals Major Business
Table 145. Azurity Pharmaceuticals GABA Receptor Modulators Product and Services
Table 146. Azurity Pharmaceuticals GABA Receptor Modulators Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 147. Azurity Pharmaceuticals Recent Developments/Updates
Table 148. Azurity Pharmaceuticals Competitive Strengths & Weaknesses
Table 149. Piramal Pharma Basic Information, Manufacturing Base and Competitors
Table 150. Piramal Pharma Major Business
Table 151. Piramal Pharma GABA Receptor Modulators Product and Services
Table 152. Piramal Pharma GABA Receptor Modulators Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 153. Piramal Pharma Recent Developments/Updates
Table 154. Piramal Pharma Competitive Strengths & Weaknesses
Table 155. Humanwell Healthcare Group Basic Information, Manufacturing Base and Competitors
Table 156. Humanwell Healthcare Group Major Business
Table 157. Humanwell Healthcare Group GABA Receptor Modulators Product and Services
Table 158. Humanwell Healthcare Group GABA Receptor Modulators Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 159. Humanwell Healthcare Group Recent Developments/Updates
Table 160. Humanwell Healthcare Group Competitive Strengths & Weaknesses
Table 161. Jiangsu Nhwa Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 162. Jiangsu Nhwa Pharmaceutical Major Business
Table 163. Jiangsu Nhwa Pharmaceutical GABA Receptor Modulators Product and Services
Table 164. Jiangsu Nhwa Pharmaceutical GABA Receptor Modulators Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 165. Jiangsu Nhwa Pharmaceutical Recent Developments/Updates
Table 166. Jiangsu Nhwa Pharmaceutical Competitive Strengths & Weaknesses
Table 167. Global Key Players of GABA Receptor Modulators Upstream (Raw Materials)
Table 168. Global GABA Receptor Modulators Typical Customers
Table 1. World GABA Receptor Modulators Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World GABA Receptor Modulators Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World GABA Receptor Modulators Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World GABA Receptor Modulators Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World GABA Receptor Modulators Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World GABA Receptor Modulators Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World GABA Receptor Modulators Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World GABA Receptor Modulators Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World GABA Receptor Modulators Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key GABA Receptor Modulators Players in 2025
Table 12. World GABA Receptor Modulators Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global GABA Receptor Modulators Company Evaluation Quadrant
Table 14. Head Office of Key GABA Receptor Modulators Players
Table 15. GABA Receptor Modulators Market: Company Product Type Footprint
Table 16. GABA Receptor Modulators Market: Company Product Application Footprint
Table 17. GABA Receptor Modulators Mergers & Acquisitions Activity
Table 18. United States VS China GABA Receptor Modulators Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China GABA Receptor Modulators Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based GABA Receptor Modulators Companies, Headquarters (States, Country)
Table 21. United States Based Companies GABA Receptor Modulators Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies GABA Receptor Modulators Revenue Market Share (2021-2026)
Table 23. China Based GABA Receptor Modulators Companies, Headquarters (Province, Country)
Table 24. China Based Companies GABA Receptor Modulators Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies GABA Receptor Modulators Revenue Market Share (2021-2026)
Table 26. Rest of World Based GABA Receptor Modulators Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies GABA Receptor Modulators Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies GABA Receptor Modulators Revenue Market Share (2021-2026)
Table 29. World GABA Receptor Modulators Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World GABA Receptor Modulators Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World GABA Receptor Modulators Market Size by Type (2027-2032) & (USD Million)
Table 32. World GABA Receptor Modulators Market Size by Pharmacological Class, (USD Million), 2021 & 2025 & 2032
Table 33. World GABA Receptor Modulators Market Size Value by Pharmacological Class (2021-2026) & (USD Million)
Table 34. World GABA Receptor Modulators Market Size by Pharmacological Class (2027-2032) & (USD Million)
Table 35. World GABA Receptor Modulators Market Size by Dosage Form, (USD Million), 2021 & 2025 & 2032
Table 36. World GABA Receptor Modulators Market Size Value by Dosage Form (2021-2026) & (USD Million)
Table 37. World GABA Receptor Modulators Market Size by Dosage Form (2027-2032) & (USD Million)
Table 38. World GABA Receptor Modulators Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 39. World GABA Receptor Modulators Market Size by Application (2021-2026) & (USD Million)
Table 40. World GABA Receptor Modulators Market Size by Application (2027-2032) & (USD Million)
Table 41. Pfizer Basic Information, Manufacturing Base and Competitors
Table 42. Pfizer Major Business
Table 43. Pfizer GABA Receptor Modulators Product and Services
Table 44. Pfizer GABA Receptor Modulators Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. Pfizer Recent Developments/Updates
Table 46. Pfizer Competitive Strengths & Weaknesses
Table 47. Viatris Basic Information, Manufacturing Base and Competitors
Table 48. Viatris Major Business
Table 49. Viatris GABA Receptor Modulators Product and Services
Table 50. Viatris GABA Receptor Modulators Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. Viatris Recent Developments/Updates
Table 52. Viatris Competitive Strengths & Weaknesses
Table 53. Teva Pharmaceutical Industries Basic Information, Manufacturing Base and Competitors
Table 54. Teva Pharmaceutical Industries Major Business
Table 55. Teva Pharmaceutical Industries GABA Receptor Modulators Product and Services
Table 56. Teva Pharmaceutical Industries GABA Receptor Modulators Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. Teva Pharmaceutical Industries Recent Developments/Updates
Table 58. Teva Pharmaceutical Industries Competitive Strengths & Weaknesses
Table 59. Sandoz Basic Information, Manufacturing Base and Competitors
Table 60. Sandoz Major Business
Table 61. Sandoz GABA Receptor Modulators Product and Services
Table 62. Sandoz GABA Receptor Modulators Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. Sandoz Recent Developments/Updates
Table 64. Sandoz Competitive Strengths & Weaknesses
Table 65. Hikma Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 66. Hikma Pharmaceuticals Major Business
Table 67. Hikma Pharmaceuticals GABA Receptor Modulators Product and Services
Table 68. Hikma Pharmaceuticals GABA Receptor Modulators Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. Hikma Pharmaceuticals Recent Developments/Updates
Table 70. Hikma Pharmaceuticals Competitive Strengths & Weaknesses
Table 71. Fresenius Kabi Basic Information, Manufacturing Base and Competitors
Table 72. Fresenius Kabi Major Business
Table 73. Fresenius Kabi GABA Receptor Modulators Product and Services
Table 74. Fresenius Kabi GABA Receptor Modulators Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. Fresenius Kabi Recent Developments/Updates
Table 76. Fresenius Kabi Competitive Strengths & Weaknesses
Table 77. B. Braun Basic Information, Manufacturing Base and Competitors
Table 78. B. Braun Major Business
Table 79. B. Braun GABA Receptor Modulators Product and Services
Table 80. B. Braun GABA Receptor Modulators Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. B. Braun Recent Developments/Updates
Table 82. B. Braun Competitive Strengths & Weaknesses
Table 83. UCB Basic Information, Manufacturing Base and Competitors
Table 84. UCB Major Business
Table 85. UCB GABA Receptor Modulators Product and Services
Table 86. UCB GABA Receptor Modulators Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. UCB Recent Developments/Updates
Table 88. UCB Competitive Strengths & Weaknesses
Table 89. Neurelis Basic Information, Manufacturing Base and Competitors
Table 90. Neurelis Major Business
Table 91. Neurelis GABA Receptor Modulators Product and Services
Table 92. Neurelis GABA Receptor Modulators Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. Neurelis Recent Developments/Updates
Table 94. Neurelis Competitive Strengths & Weaknesses
Table 95. Eagle Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 96. Eagle Pharmaceuticals Major Business
Table 97. Eagle Pharmaceuticals GABA Receptor Modulators Product and Services
Table 98. Eagle Pharmaceuticals GABA Receptor Modulators Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. Eagle Pharmaceuticals Recent Developments/Updates
Table 100. Eagle Pharmaceuticals Competitive Strengths & Weaknesses
Table 101. Cosette Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 102. Cosette Pharmaceuticals Major Business
Table 103. Cosette Pharmaceuticals GABA Receptor Modulators Product and Services
Table 104. Cosette Pharmaceuticals GABA Receptor Modulators Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. Cosette Pharmaceuticals Recent Developments/Updates
Table 106. Cosette Pharmaceuticals Competitive Strengths & Weaknesses
Table 107. Supernus Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 108. Supernus Pharmaceuticals Major Business
Table 109. Supernus Pharmaceuticals GABA Receptor Modulators Product and Services
Table 110. Supernus Pharmaceuticals GABA Receptor Modulators Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 111. Supernus Pharmaceuticals Recent Developments/Updates
Table 112. Supernus Pharmaceuticals Competitive Strengths & Weaknesses
Table 113. Biogen Basic Information, Manufacturing Base and Competitors
Table 114. Biogen Major Business
Table 115. Biogen GABA Receptor Modulators Product and Services
Table 116. Biogen GABA Receptor Modulators Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 117. Biogen Recent Developments/Updates
Table 118. Biogen Competitive Strengths & Weaknesses
Table 119. Immedica Pharma Basic Information, Manufacturing Base and Competitors
Table 120. Immedica Pharma Major Business
Table 121. Immedica Pharma GABA Receptor Modulators Product and Services
Table 122. Immedica Pharma GABA Receptor Modulators Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 123. Immedica Pharma Recent Developments/Updates
Table 124. Immedica Pharma Competitive Strengths & Weaknesses
Table 125. Jazz Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 126. Jazz Pharmaceuticals Major Business
Table 127. Jazz Pharmaceuticals GABA Receptor Modulators Product and Services
Table 128. Jazz Pharmaceuticals GABA Receptor Modulators Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 129. Jazz Pharmaceuticals Recent Developments/Updates
Table 130. Jazz Pharmaceuticals Competitive Strengths & Weaknesses
Table 131. Alkermes Basic Information, Manufacturing Base and Competitors
Table 132. Alkermes Major Business
Table 133. Alkermes GABA Receptor Modulators Product and Services
Table 134. Alkermes GABA Receptor Modulators Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 135. Alkermes Recent Developments/Updates
Table 136. Alkermes Competitive Strengths & Weaknesses
Table 137. Amneal Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 138. Amneal Pharmaceuticals Major Business
Table 139. Amneal Pharmaceuticals GABA Receptor Modulators Product and Services
Table 140. Amneal Pharmaceuticals GABA Receptor Modulators Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 141. Amneal Pharmaceuticals Recent Developments/Updates
Table 142. Amneal Pharmaceuticals Competitive Strengths & Weaknesses
Table 143. Azurity Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 144. Azurity Pharmaceuticals Major Business
Table 145. Azurity Pharmaceuticals GABA Receptor Modulators Product and Services
Table 146. Azurity Pharmaceuticals GABA Receptor Modulators Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 147. Azurity Pharmaceuticals Recent Developments/Updates
Table 148. Azurity Pharmaceuticals Competitive Strengths & Weaknesses
Table 149. Piramal Pharma Basic Information, Manufacturing Base and Competitors
Table 150. Piramal Pharma Major Business
Table 151. Piramal Pharma GABA Receptor Modulators Product and Services
Table 152. Piramal Pharma GABA Receptor Modulators Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 153. Piramal Pharma Recent Developments/Updates
Table 154. Piramal Pharma Competitive Strengths & Weaknesses
Table 155. Humanwell Healthcare Group Basic Information, Manufacturing Base and Competitors
Table 156. Humanwell Healthcare Group Major Business
Table 157. Humanwell Healthcare Group GABA Receptor Modulators Product and Services
Table 158. Humanwell Healthcare Group GABA Receptor Modulators Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 159. Humanwell Healthcare Group Recent Developments/Updates
Table 160. Humanwell Healthcare Group Competitive Strengths & Weaknesses
Table 161. Jiangsu Nhwa Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 162. Jiangsu Nhwa Pharmaceutical Major Business
Table 163. Jiangsu Nhwa Pharmaceutical GABA Receptor Modulators Product and Services
Table 164. Jiangsu Nhwa Pharmaceutical GABA Receptor Modulators Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 165. Jiangsu Nhwa Pharmaceutical Recent Developments/Updates
Table 166. Jiangsu Nhwa Pharmaceutical Competitive Strengths & Weaknesses
Table 167. Global Key Players of GABA Receptor Modulators Upstream (Raw Materials)
Table 168. Global GABA Receptor Modulators Typical Customers
LIST OF FIGURES
Figure 1. GABA Receptor Modulators Picture
Figure 2. World GABA Receptor Modulators Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World GABA Receptor Modulators Total Revenue (2021-2032) & (USD Million)
Figure 4. World GABA Receptor Modulators Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World GABA Receptor Modulators Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company GABA Receptor Modulators Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company GABA Receptor Modulators Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company GABA Receptor Modulators Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company GABA Receptor Modulators Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company GABA Receptor Modulators Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company GABA Receptor Modulators Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company GABA Receptor Modulators Revenue (2021-2032) & (USD Million)
Figure 13. GABA Receptor Modulators Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World GABA Receptor Modulators Consumption Value (2021-2032) & (USD Million)
Figure 16. World GABA Receptor Modulators Consumption Value Market Share by Region (2021-2032)
Figure 17. United States GABA Receptor Modulators Consumption Value (2021-2032) & (USD Million)
Figure 18. China GABA Receptor Modulators Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe GABA Receptor Modulators Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan GABA Receptor Modulators Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea GABA Receptor Modulators Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN GABA Receptor Modulators Consumption Value (2021-2032) & (USD Million)
Figure 23. India GABA Receptor Modulators Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of GABA Receptor Modulators by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for GABA Receptor Modulators Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for GABA Receptor Modulators Markets in 2025
Figure 27. United States VS China: GABA Receptor Modulators Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: GABA Receptor Modulators Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World GABA Receptor Modulators Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World GABA Receptor Modulators Market Size Market Share by Type in 2025
Figure 31. GABAA Receptor Modulators
Figure 32. GABAB Receptor Modulators
Figure 33. World GABA Receptor Modulators Market Size Market Share by Type (2021-2032)
Figure 34. World GABA Receptor Modulators Market Size by Pharmacological Class, (USD Million), 2021 & 2025 & 2032
Figure 35. World GABA Receptor Modulators Market Size Market Share by Pharmacological Class in 2025
Figure 36. Benzodiazepines
Figure 37. Z-drugs
Figure 38. Barbiturates
Figure 39. Other
Figure 40. World GABA Receptor Modulators Market Size Market Share by Pharmacological Class (2021-2032)
Figure 41. World GABA Receptor Modulators Market Size by Dosage Form, (USD Million), 2021 & 2025 & 2032
Figure 42. World GABA Receptor Modulators Market Size Market Share by Dosage Form in 2025
Figure 43.Tablets and Capsules
Figure 44. Oral Liquids and Suspensions
Figure 45. Injectable Solutions
Figure 46. Other
Figure 47. World GABA Receptor Modulators Market Size Market Share by Dosage Form (2021-2032)
Figure 48. World GABA Receptor Modulators Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 49. World GABA Receptor Modulators Market Size Market Share by Application in 2025
Figure 50. Hospital
Figure 51. Clinic
Figure 52. Others
Figure 53. World GABA Receptor Modulators Market Size Market Share by Application (2021-2032)
Figure 54. GABA Receptor Modulators Industrial Chain
Figure 55. Methodology
Figure 56. Research Process and Data Source
Figure 1. GABA Receptor Modulators Picture
Figure 2. World GABA Receptor Modulators Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World GABA Receptor Modulators Total Revenue (2021-2032) & (USD Million)
Figure 4. World GABA Receptor Modulators Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World GABA Receptor Modulators Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company GABA Receptor Modulators Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company GABA Receptor Modulators Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company GABA Receptor Modulators Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company GABA Receptor Modulators Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company GABA Receptor Modulators Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company GABA Receptor Modulators Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company GABA Receptor Modulators Revenue (2021-2032) & (USD Million)
Figure 13. GABA Receptor Modulators Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World GABA Receptor Modulators Consumption Value (2021-2032) & (USD Million)
Figure 16. World GABA Receptor Modulators Consumption Value Market Share by Region (2021-2032)
Figure 17. United States GABA Receptor Modulators Consumption Value (2021-2032) & (USD Million)
Figure 18. China GABA Receptor Modulators Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe GABA Receptor Modulators Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan GABA Receptor Modulators Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea GABA Receptor Modulators Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN GABA Receptor Modulators Consumption Value (2021-2032) & (USD Million)
Figure 23. India GABA Receptor Modulators Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of GABA Receptor Modulators by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for GABA Receptor Modulators Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for GABA Receptor Modulators Markets in 2025
Figure 27. United States VS China: GABA Receptor Modulators Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: GABA Receptor Modulators Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World GABA Receptor Modulators Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World GABA Receptor Modulators Market Size Market Share by Type in 2025
Figure 31. GABAA Receptor Modulators
Figure 32. GABAB Receptor Modulators
Figure 33. World GABA Receptor Modulators Market Size Market Share by Type (2021-2032)
Figure 34. World GABA Receptor Modulators Market Size by Pharmacological Class, (USD Million), 2021 & 2025 & 2032
Figure 35. World GABA Receptor Modulators Market Size Market Share by Pharmacological Class in 2025
Figure 36. Benzodiazepines
Figure 37. Z-drugs
Figure 38. Barbiturates
Figure 39. Other
Figure 40. World GABA Receptor Modulators Market Size Market Share by Pharmacological Class (2021-2032)
Figure 41. World GABA Receptor Modulators Market Size by Dosage Form, (USD Million), 2021 & 2025 & 2032
Figure 42. World GABA Receptor Modulators Market Size Market Share by Dosage Form in 2025
Figure 43.Tablets and Capsules
Figure 44. Oral Liquids and Suspensions
Figure 45. Injectable Solutions
Figure 46. Other
Figure 47. World GABA Receptor Modulators Market Size Market Share by Dosage Form (2021-2032)
Figure 48. World GABA Receptor Modulators Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 49. World GABA Receptor Modulators Market Size Market Share by Application in 2025
Figure 50. Hospital
Figure 51. Clinic
Figure 52. Others
Figure 53. World GABA Receptor Modulators Market Size Market Share by Application (2021-2032)
Figure 54. GABA Receptor Modulators Industrial Chain
Figure 55. Methodology
Figure 56. Research Process and Data Source
